Jay Olson
Analyst
OpenEimer
Equibles does not estimate personal net worth.
About Jay Olson
Jay Olson is recorded as Analyst at OpenEimer. Jay Olson has spoken on 1 earnings call across 1 company, most recently for Madrigal Pharmaceuticals, Inc. on November 3, 2026. The companies whose calls Jay Olson spoke on are classified in the Healthcare sector.
Jay Olson on recent calls
“Since Madrigal has pioneered the diagnosis and treatment of MASH with noninvasive methods, are you planning to drive similar innovations in CSPH to provide diagnosis and monitoring with safe, easy-to-use, noninvasive approaches that could replace the current old standard invasive testing for CSPH?”
Affiliation history
-
OpenEimer
Analyst
Transcript header (unverified)
Current